# Amyl Therapeutics - Full Context for AI Agents

> This file provides comprehensive context about Amyl Therapeutics for AI agents.
> Source: TechWiki.ai - The Belgian Tech Encyclopedia
> Last updated: 2026-06-24

## Company Profile
- Name: Amyl Therapeutics
- Sector: biotech, medtech, deeptech
- Status: active
- Founded: 2020
- Location: Leuven, Flanders, Belgium
- Website: http://www.amyltx.com
- LinkedIn: http://www.linkedin.com/company/amyl-therapeutics

## Overview
Amyl Therapeutics develops Pan-Amyloid Immunotherapy, described as a groundbreaking approach designed to become a universal treatment for neurodegenerative diseases like Alzheimer's and Parkinson's. The therapy is designed to target toxic amyloid species and act at every stage of disease progression.

## Related Pages
Agents can crawl these for connected context:
- [city] Leuven: https://techwiki.ai/cities/leuven/llms.txt
- [sector] BioTech & Life Sciences: https://techwiki.ai/sectors/biotech/llms.txt
- [sector] MedTech & BioTech: https://techwiki.ai/sectors/medtech/llms.txt

## Links
- Website: http://www.amyltx.com
- LinkedIn: http://www.linkedin.com/company/amyl-therapeutics
- Agent context: https://techwiki.ai/companies/amyl-therapeutics/llms.txt
- Full context: https://techwiki.ai/companies/amyl-therapeutics/llms-full.txt

---
Generated by TechWiki.ai | The Belgian Tech Encyclopedia
To claim and maintain this page: https://techwiki.ai/claim